If you made any changes in Pure these will be visible here soon.

Personal profile

Research interests

In the immune response to cancer, tumour-derived mutated peptides are recognised by T cells, central regulatory and cytolytic effectors of the immune system, through binding of the T cell receptor (TCR) to the MHC-presented peptides on the tumour cell surface. TCR signals are enhanced by co-stimulatory receptors such as CD2 and CD28, and suppressed by co-inhibitory receptors, five of which are most intensively studied: CTLA-4, PD-1, LAG-3, TIM-3 and TIGIT. Increased expression of inhibitory receptors in tumour infiltrating lymphocytes significantly limits their ability to eliminate cancer cells, thus allowing tumours to evade the immune response. Antibodies blocking co-inhibitory receptors or their ligands show great clinical promise in the treatment of various cancers through reactivation of an effective anti-tumour immune response. However, as autoimmune side effects are common and efficacy is variable more research into the mechanism of action of inhibitory receptors is required.


Dive into the research topics where Jiahe Lu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 6 Similar Profiles


Recent external collaboration on country level. Dive into details by clicking on the dots or
If you made any changes in Pure these will be visible here soon.